Skip to main content

Therapeutic Considerations from Pharmacokinetics and Metabolism: Ibuprofen and Paracetamol

  • Chapter

Abstract

Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID). It exists as two enantiomers (R and S ibuprofen) but only the S form is considered to have the many activities of this class of drug, effects such as analgesic, anti-inflammatory, anti-pyretic and anti-platelet actions. These pharmacological properties have been related to inhibition of prostaglandin H synthase although there is still doubt that all the pharmacological activities of this or other NSAIDs are the result only of inhibition of the synthesis of prostanoids.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Williams KM. Molecular asymmetry and its pharmacological consequences. Adv Pharmacol. 1991;2:57–135.

    Article  Google Scholar 

  2. Kelley MT, Walson PD, Edge JH, Cox S, Mortensen ME. Pharmacokinetics and pharmacodynamics of ibuprofen and acetaminophen in febrile children. Clin Pharmacol Ther. 1992;52:181–9.

    Article  PubMed  CAS  Google Scholar 

  3. Menzel S, Waibel R, Brune K, Geisslinger G. Is the formation of R-ibuprofenyl-adenylate the first stereoselective step of chiral inversion? Biochem Pharmacol. 1994;48:1056–8.

    Article  PubMed  CAS  Google Scholar 

  4. Williams KM, Day R, Knihinicki R, Duffield A. The stereoselective uptake of ibuprofen enantiomers into adipose tissue. Biochem Pharmacol. 1986;35:3403–5.

    Article  PubMed  CAS  Google Scholar 

  5. Williams KM, Nelson CJ, Lohrer F, Ellis B, Tattum B, Day RO. Ibuprofen cholesterol esters. J Clin Pharmacol. 1995;35:939.

    Google Scholar 

  6. Ellis BA, Nelson C, Day RO, Williams KM. Characterization of non-steroidal anti-inflammatory drug (NSAID) thioesters as inhibitors of carnitine palmitoyl transferase in rat liver. Proc ASCEPT. 1996;3:131.

    Google Scholar 

  7. Zhao B, Geisslinger G, Hall I, Day RO, Williams KM. The effect of the enantiomers of ibuprofen and flurbiprofen on the β-oxidation of palmitate in the rat. Chirality. 1992;4:137–41.

    Article  PubMed  CAS  Google Scholar 

  8. Williams KM, Browne G, Nelson CJ, Nguyen T, Day RO. Effects of 2-arylpropionic acids on the β- oxidation of fatty acids. J Clin Pharmacol. 1995;35:938.

    Google Scholar 

  9. Freneaux E, Fromenty B, Berson A et al. Stereoselective and non-selective effects of ibuprofen enantiomers on mitochondrial β-oxidation of fatty acids. J Pharmacol Exp Ther. 1990;255:529–35.

    PubMed  CAS  Google Scholar 

  10. Evans AM, Nation RL, Sansom LN. Lack of effect of cimetidine on the pharmacokinetics of R(-) and S(+)-ibuprofen. Br J Clin Pharmacol. 1989;28:143–9.

    Article  CAS  Google Scholar 

  11. Evans AM, Pharmacodynamics and pharmacokinetics of the profens: Enantioselectivity, clinical implications, and special reference to S(+)-ibuprofen. J Clin Pharmacol. 1996;36:7S–15S.

    PubMed  CAS  Google Scholar 

  12. Scheuerer S, Oelkers R, Brune K, Williams KM, Geisslinger G. Effect of clofibrate on the chiral inversion of ibuprofen in healthy volunteers. Naunyn-Schmiedebergs Arch Pharamcol. 1996;353(Suppl):R 147.

    Google Scholar 

  13. Avgerinos A, Hutt AJ. Interindividual variability in the enantiomeric disposition of ibuprofen following the oral administration of the racemic drug to healthy volunteers. Chiralty. 1990;2:249–56.

    Article  CAS  Google Scholar 

  14. Smith DE, Paliwal JK, Cox SR, Berardi RR, Dunn-Kucharski VA, Elta GH. The effect of competitive and non-linear plasma protein binding on the stereoselective disposition and metabolite inversion of ibuprofen in healthy subjects. Biopharm Drug Dispos. 1994;15:545–61.

    Article  PubMed  CAS  Google Scholar 

  15. Li G, Treiber G, Maier K, Walker S, Klotz U. Disposition of ibuprofen in patients with liver cirrhosis. Stereochemical considerations. Clin Pharmacokinet. 1993;25:154–63.

    Article  PubMed  CAS  Google Scholar 

  16. Evans AM, Nation RL, Sansom LN, Bochner F, Somogyi AA. The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humans. Biopharm Drug Dispos. 1990;11:507–18.

    Article  PubMed  CAS  Google Scholar 

  17. Paliwal JK, Smith DE, Cox SR, Berardi RR, Dunn-Kucharski VA, Elta GH. Stereoselective, competitive and nonlinear plasma protein binding of ibuprofen enantiomers as determined in vivo in healthy subjects. J Pharmacokinet Biopharm. 1993;21:145–61.

    PubMed  CAS  Google Scholar 

  18. Villanueva M, Heckenberger R, Strobach H, Palmér M, Schrör K. Equipotent inhibition by R(-), S(+)-and racemic ibuprofen of human polymorphonuclear cell function in vitro. Br J Clin Pharmacol. 1993;35:235–42.

    Article  CAS  Google Scholar 

  19. Graham GG, Tsui D, Torda TA. A simplified approach to the effect kinetics of atracurium. Br J Anaesth. 1990;64:28–32.

    Article  PubMed  CAS  Google Scholar 

  20. Day RO, Williams KM, Graham GG, Lee EJ, Knihinicki RD, Champion GD. Stereoselective disposition of ibuprofen enantiomers in synovial fluid. Clin Pharmacol Ther. 1988;43:480–7.

    Article  PubMed  CAS  Google Scholar 

  21. Seideman P, Lohrer F, Graham GG, Duncan MW, Williams KM, Day RO. The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluid. Br J Clin Pharmacol. 1994;38:221–7.

    Article  PubMed  CAS  Google Scholar 

  22. Blaser J, Rieder HI, Luthy R. Interface-area-to-volume ratio of interstitial fluid in humans determined by pharmacokinetic analysis of netilmicin in small and large skin blisters. Antimicrob Agents Chemother. 1991;35:837–9.

    Article  PubMed  CAS  Google Scholar 

  23. Lötsch J, Geisslinger G, Mohammadian P, Brune K, Kobal G. Effects of flurbiprofen enantiomers on pain-related chematosensory evoked potentials in human subjects. Br J Clin Pharmacol. 1995;40:33946.

    Google Scholar 

  24. Oelkers R, Neupert W, Williams KM, Brune K, Geisslinger G. Disposition and effects of flurbiprofen enantiomers in human serum and blister fluid. Br J Clin Pharmacol. 1997;43:145–53.

    Article  PubMed  CAS  Google Scholar 

  25. Wechter WJ, McCracken JD, Kantoci D et al. Enhancement of ulcer formation and antiproliferative effects of R-flurbiprofen. Presented at Inflammopharmacology Symposium, San Francisco, CA, March 1997.

    Google Scholar 

  26. McCracken JD, Liu Y, Chase RL et al. Antiproliferative effects of the enantiomers of flurbiprofen. J Clin Pharmacol. 1996;36:540–5.

    CAS  Google Scholar 

  27. Giannakopoulos B, Perry MA, Williams KM, Antoon JS. Intestinal injury caused by S, R and RSflurbiprofen under conditions of altered osmolality. Proc ASCEPT. 1996;3:64.

    Google Scholar 

  28. Prescott LF, Speirs GC, Critchley JAJH, Temple RM, Winney RJ. Paracetamol disposition and metabolite kinetics in patients with chronic renal failure. Eur J Clin Pharmacol. 1989;36:291–7.

    Article  PubMed  CAS  Google Scholar 

  29. Baraka OZ, Truman CA, Ford JM, Roberts CJC. The effect of propranolol on paracetamol metabolism in man. Br J Clin Pharmacol. 1990;29:261–4.

    Article  CAS  Google Scholar 

  30. Bannwarth B, Netter P, Lapicque F et al. Plasma and cerebrospinal fluid concentrations of paracetamol after a single intravenous dose of propacetamol. Br J Clin Pharmacol. 1992;34:79–81.

    Article  CAS  Google Scholar 

  31. Moreau X, Le Quay L, Granry JC, Boishardy N, Delhumeau A. Pharmacokinetics of paracetamol in the cerebrospinal fluid in the elderly. Therapie. 1993;48:393–6.

    PubMed  CAS  Google Scholar 

  32. Brown RD, Wilson JT, Kearns GL, Eichler VF, Johnson VA, Bertrand KM. Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile children J Clin Pharmacol. 1992;32:231–41.

    PubMed  CAS  Google Scholar 

  33. Piletta P, Porchet HC, Dayer P. Central analgesic effect of acetaminophen but not of aspirin. Clin Pharmacol Ther. 1991;49:350–4.

    Article  PubMed  CAS  Google Scholar 

  34. Seymour RA, Rawlins MD. Pharmacokinetics of parenteral paracetamol and its analgesic effects in post-operative dental pain. Eur J Clin Pharmacol. 1981;20:215–8.

    Article  PubMed  CAS  Google Scholar 

  35. Flinn FB, Brodie BB. The effect on the pain threshold of N-acetyl p-aminophenol, a product derived in the body from acetanilide. J Pharmacol Exp Ther. 1948;94:76–7.

    PubMed  CAS  Google Scholar 

  36. Nelson E, Morioka T. Kinetics of the metabolism of acetaminophen by humans. J Pharm Sci. 1963;52:864–8.

    Article  PubMed  CAS  Google Scholar 

  37. Quiding H, Oikarinen V, Sane J, Sjöblad A-M. Analgesic efficacy after single and repeated doses of codeine and acetaminophen. J Clin Pharmacol. 1984;24:27–34.

    PubMed  CAS  Google Scholar 

  38. Levy G. Pharmacokinetic analysis of the analgesic effect of a second dose of acetaminophen in humans. J Pharm Sci. 1987;76:88–9.

    Article  PubMed  CAS  Google Scholar 

  39. Cooper SA, Schachtel BP, Goldman E, Gelb S, Cohn P. Ibuprofen and acetaminophen in the relief of acute pain: A randomized, double-blind, placebo-controlled study. J Clin Pharmacol. 1989;29:1026–30.

    PubMed  CAS  Google Scholar 

  40. Owen SG, Francis HW, Roberts MS. Disappearance kinetics of solutes from synovial fluid after infra-articular injection. Br J Clin Pharmacol. 1994;38:349–55.

    Article  PubMed  CAS  Google Scholar 

  41. Marquez LA, Dunford HB. Interaction of acetaminophen with myeloperoxidase intermediates: optimum stimulation of enzyme activity. Arch Biochem Biophys. 1993;305:414–20.

    Article  PubMed  CAS  Google Scholar 

  42. van Zyl JM, Basson K, van der Walt B. The inhibitory effect of acetaminophen on the myeloperoxidaseinduced antimicrobial system of the polymorphonuclear leukocyte. Biochem Pharmacol. 1989;38:1615.

    Google Scholar 

  43. Shalabi EA. Acetaminophen inhibits the human polymorphonuclear function in vitro. Immunopharmacology. 1992;24:37–46.

    Article  PubMed  CAS  Google Scholar 

  44. Milligan MK, Newsham DW, Nguyen L, Spicer F, Graham GG, Ziegler JB. Metabolism of paracetamol and inhibition of hypochlorous acid formation by neutrophils. Proc ASCEPT. 1996;3:65.

    Google Scholar 

  45. O’Brien PJ, Khan S, Jatoe SD. Formation of biological reactive intermediates by peroxidases: halide mediated acetaminophen oxidation and cytotoxicity. Adv Exp Med Biol. 1990;283:51–64.

    Article  Google Scholar 

  46. Seideman PJ. Additive effect of combined naproxen and paracetamol in rheumatoid arthritis. Br J R heumatol. 1993;32:1077–82.

    CAS  Google Scholar 

  47. Corbett MD, Corbett BR, Hannothiaux M-H, Quintana SJ. Metabolic activation and nucleic acid binding of acetaminophen and related arylamine substrates by the respiratory burst of human granulocytes. Chem Res Toxicol. 1989;2:260–6.

    Article  PubMed  CAS  Google Scholar 

  48. Mason RP, Fisher V. Possible role of free radical formation in drug-induced agranulocytosis. Drug Safety. 1992;7(suppl 1):45–50.

    Article  PubMed  CAS  Google Scholar 

  49. Potter DW, Hinson JA. The 1- and 2-electron oxidation of acetaminophen catalyzed by prostaglandin H synthase. J Biol Chem. 1987;262:974–80.

    PubMed  CAS  Google Scholar 

  50. Harvison PJ, Egan RW, Gale PH, Nelson SD. Acetaminophen as a cosubstrate and inhibitor of prostaglandin H synthase. Adv Exp Med Biol. 1985;197:739–47.

    Article  Google Scholar 

  51. Lands WEM, Cook HW, Rome LH. Prostaglandin biosynthesis; the consequences of oxygenase mechanism upon in vitro assays of drug effectiveness. Adv Prostagland Thrombox Res. 1976;1:7–17.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Graham, G.G., Milligan, M.K., Day, R.O., Williams, K.M., Ziegler, J.B. (1998). Therapeutic Considerations from Pharmacokinetics and Metabolism: Ibuprofen and Paracetamol. In: Rainsford, K.D., Powanda, M.C. (eds) Safety and Efficacy of Non-Prescription (OTC) Analgesics and NSAIDs. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4878-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4878-8_6

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6044-8

  • Online ISBN: 978-94-011-4878-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics